Madrigal Pharmaceuticals (MDGL) Stock Price, Quote, News & History

Comments

Madrigal Pharmaceuticals Inc (MDGL) Stock Price, Quote, News & History

MDGLNASDAQ

Trade with Public

$440.83

-4.00-0.90%

At close: Mar 16, 5:00 PM EST

$440.83

N/A

After Hours: 4:00 PM EST

OverviewNews Earnings Options Analyst Ratings Insider Trades Short Interest Government Trades Stock Report

Key Statistics

Open

$446.84

Close

$440.83

Volume / Avg.

360.24K / 345.46K

Day Range

$440.00 - $455.00

52 Wk Range

265.00 - 615.00

Market Cap

$9.83B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

44

Short Interest

19.45%

Days to Cover

8.16

Recent Madrigal Pharmaceuticals Inc News

Madrigal Pharmaceuticals Stock: A Deep Dive Into Analyst Perspectives (5 Ratings)

Benzinga Insights

PRO
Madrigal Pharmaceuticals shares are trading lower after the company reported mixed Q4 financial results.

Benzinga Newsdesk

PRO
Madrigal Pharmaceuticals Q4 2025 EPS $(2.57) Misses $(0.40) Estimate, Sales $321.083M Beat $312.490M Estimate

Benzinga Newsdesk

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-160.58M

Investing Cash Flow (TTM)

-43.21M

Financing Cash Flow (TTM)

266.80M

Free Cash Flow (TTM)

-164.63M

Capital Expenditure (TTM)

-4.05M

Net Change in Cash (TTM)

63.01M

Analyst Trends and Forecast

6

1

Nov 25

2

Dec 25

1

Jan

1

Feb

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$9.34B

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

10.41

PB Ratio (TTM)

16.76

Earnings Yield % (TTM)

-2.89%

Earnings Yield % (FWD)

-1.16%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$26.54

Company Debt

Total Debt

$339.75M

LT Debt

$339.75M

LT Debt Issuance (TTM)

$350.00M

LT Debt Repayment (TTM)

-

Total Cash

$295.69M

Debt to Equity

-

Issuance of Debt (TTM)

$228.34M

Repayment of Debt (TTM)

-

Key Statistics

Open

$446.84

Close

$440.83

Volume / Avg.

360.24K / 345.46K

Day Range

$440.00 - $455.00

52 Wk Range

265.00 - 615.00

Market Cap

$9.83B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

44

Short Interest

19.45%

Days to Cover

8.16

About

Sector

Health Care

Industry

Biotechnology

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver f...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Madrigal Pharmaceuticals (MDGL) stock?

A

You can purchase shares of Madrigal Pharmaceuticals (NASDAQ:MDGL) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Madrigal Pharmaceuticals (MDGL) competitors?

A

Other companies in Madrigal Pharmaceuticals’s space includes: Exact Sciences Corp (NASDAQ:EXAS), Neurocrine Biosciences Inc (NASDAQ:NBIX), Ionis Pharmaceuticals Inc (NASDAQ:IONS), Roivant Sciences Ltd (NASDAQ:ROIV) and Vaxcyte Inc (NASDAQ:PCVX).

Q

What is the forecast, or price target, for Madrigal Pharmaceuticals (MDGL) stock?

A

Madrigal Pharmaceuticals has a consensus price target of $590.76.

Q

What is the current price for Madrigal Pharmaceuticals (MDGL)?

A

The stock price for Madrigal Pharmaceuticals (NASDAQ: MDGL) is $440.83 last updated March 16, 2026 at 4:00 PM EDT.

Q

Does Madrigal Pharmaceuticals (MDGL) pay a dividend?

A

There are no upcoming dividends for Madrigal Pharmaceuticals.

Q

When is Madrigal Pharmaceuticals (NASDAQ:MDGL) reporting earnings?

A

Madrigal Pharmaceuticals does not have any upcoming earnings scheduled.

Q

Is Madrigal Pharmaceuticals (MDGL) going to split?

A

There is no upcoming split for Madrigal Pharmaceuticals.

Q

What sector and industry does Madrigal Pharmaceuticals (MDGL) operate in?

A

Madrigal Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch

Neurocrine Biosciences Inc

NASDAQ:NBIX

$129.85

%

Ionis Pharmaceuticals Inc

Protagonist Therapeutics Inc

NASDAQ:PTGX

$96.75

%

Arrowhead Pharmaceuticals Inc

NASDAQ:ARWR

$57.20

-0.30%

BioMarin Pharmaceutical Inc

NASDAQ:BMRN

$57.43

%

Key Statistics

Open

$446.84

Close

$440.83

Volume / Avg.

360.24K / 345.46K

Day Range

$440.00 - $455.00

52 Wk Range

265.00 - 615.00

Market Cap

$9.83B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

44

Short Interest

19.45%

Days to Cover

8.16

Recent Madrigal Pharmaceuticals Inc News

Madrigal Pharmaceuticals Stock: A Deep Dive Into Analyst Perspectives (5 Ratings)

Benzinga Insights

PRO
Madrigal Pharmaceuticals shares are trading lower after the company reported mixed Q4 financial results.

Benzinga Newsdesk

PRO
Madrigal Pharmaceuticals Q4 2025 EPS $(2.57) Misses $(0.40) Estimate, Sales $321.083M Beat $312.490M Estimate

Benzinga Newsdesk

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-160.58M

Investing Cash Flow (TTM)

-43.21M

Financing Cash Flow (TTM)

266.80M

Free Cash Flow (TTM)

-164.63M

Capital Expenditure (TTM)

-4.05M

Net Change in Cash (TTM)

63.01M

Analyst Trends and Forecast

6

1

Nov 25

2

Dec 25

1

Jan

1

Feb

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$9.34B

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

10.41

PB Ratio (TTM)

16.76

Earnings Yield % (TTM)

-2.89%

Earnings Yield % (FWD)

-1.16%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$26.54

Company Debt

Total Debt

$339.75M

LT Debt

$339.75M

LT Debt Issuance (TTM)

$350.00M

LT Debt Repayment (TTM)

-

Total Cash

$295.69M

Debt to Equity

-

Issuance of Debt (TTM)

$228.34M

Repayment of Debt (TTM)

-

Key Statistics

Open

$446.84

Close

$440.83

Volume / Avg.

360.24K / 345.46K

Day Range

$440.00 - $455.00

52 Wk Range

265.00 - 615.00

Market Cap

$9.83B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

44

Short Interest

19.45%

Days to Cover

8.16

About

Sector

Health Care

Industry

Biotechnology

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver f...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry